Showing results (1871-1880 of 1,880) with videos related to

Sort By:
Pageof 188
You have reached the last page of results.This site can display upto 1,880 results.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Journal of Medicinal Chemistry|May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple SclerosisMartin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
World Journal of Hepatology|May 31, 2024
Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort studyYuan-Yao Zhang, Sen Luo, Hai Li, et al.
Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.
Arthroplasty (London, England)|February 14, 2026
Chinese expert consensus on the surgical treatment of femoral neck fracture by direct anterior approach hip arthroplasty for elderly patients (2025 edition)Xiaojun Man, Zhaxi Mima, Zhonghua Xu, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
JAMA Oncology|March 19, 2026
Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal CarcinomaSu-Chen Li, Fu-Gui Li, Shi-Ji Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 29, 2020
Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute DecompensationYan Zhang, Bao-Yan Xu, Xian-Bo Wang, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Zhao-Hui Zheng, Ding Wei, et al.
Nature Communications|August 24, 2016
Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritisSolveig K Sieberts, Fan Zhu, Javier García-García, et al.
Pageof 188